MosaiQ AiPlex CTD Assay
Multiplex autoantibody profiling in one automated run
A connective tissue disease multiplex assay for the MosaiQ platform that profiles multiple autoantibody specificities in a single automated run to support autoimmune work-up.
The MosaiQ AiPlex CTD Assay from AliveDx is a multiplex reagent panel for connective tissue disease (CTD) testing on the automated MosaiQ platform. Instead of running autoantibody markers across separate, sequential workflows, the assay measures a panel of clinically relevant CTD autoantibody specificities in a single automated run, helping laboratories provide a broader immunological profile from one sample.
Connective tissue diseases such as systemic lupus erythematosus, Sjogren's syndrome and systemic sclerosis often present with overlapping clinical features, which can make assessment challenging. By consolidating multiple autoantibody specificities into one workflow, the AiPlex CTD Assay is intended to streamline laboratory autoantibody testing and support clinicians as part of the overall diagnostic work-up.
Distributed in India by Biostate DX, the assay brings AliveDx's multiplexing technology to Indian immunology and autoimmune testing laboratories, pairing multi-marker panel coverage with the walk-away automation and consolidated reporting of the MosaiQ system. Results should be interpreted in conjunction with clinical findings and other laboratory data.
- Multiplex CTD autoantibody profiling delivered from a single automated run
- Consolidates multiple autoantibody specificities into one laboratory workflow
- Intended to streamline autoantibody testing for connective tissue disease assessment
- Runs on the automated MosaiQ platform for walk-away, hands-off operation
- Single-sample workflow helps conserve specimen volume
- Consolidated multi-marker reporting supports laboratory interpretation
- Reduces reliance on separate, sequential autoantibody assays
- Backed by Biostate DX distribution and support across India
At a glance
- Assay type
- Multiplex connective tissue disease (CTD) autoantibody assay
- Platform
- MosaiQ automated immunoassay system
- Panel scope
- Multiple CTD autoantibody specificities measured in a single run
- Automation
- Automated, walk-away workflow
- Sample handling
- Single-sample, multiplexed analysis
- Intended use
- Aid in the diagnosis of connective tissue diseases, in conjunction with clinical findings
- Reporting
- Consolidated multi-marker autoantibody report
- Principal / brand
- AliveDx (MosaiQ)
Specifications are indicative and provided for general guidance. Exact configurations, claims and regulatory status vary by model and region — contact us for the current datasheet.
You may also need
Interested in MosaiQ AiPlex CTD Assay?
Request pricing, a datasheet or a hands-on demonstration. Our specialists will tailor a recommendation to your laboratory's workflow and volumes.